In gallbladder cancer (GBC), KIF11 facilitated tumor growth via the ERBB2/PI3K/Akt signaling pathway, and the histone acetylation modification (H3K27ac) positively modulated KIF11 expression. Here, KIF11 is linked to neoplasm.